Potential Drug Target Or Breast Cancer Biomarker SCCPDH (G51097)

Target Name: SCCPDH

NCBI ID: G51097

SCCPDH

Potential Drug Target Or Breast Cancer Biomarker SCCPDH

SCCPDH (stimulated cancer cell proliferation-derived hybridoma) is a protein that is expressed in various types of cancer cells. It is also known as OTTHUMP00000038085. SCCPDH is a potential drug target or biomarker for various types of cancer.

SCCPDH is a transcription factor that plays a role in the regulation of cell proliferation. It is expressed in various types of cancer cells, including lung, breast, and ovarian cancer cells. It is also found in normal tissues, such as the skin and the uterus.

SCCPDH has been shown to promote the growth and proliferation of cancer cells. It is also associated with the development of various types of cancer, including breast cancer.

SCCPDH is a potential drug target because it is involved in the regulation of cell proliferation. This makes it an attractive target for cancer treatments because it can be inhibited using small molecules or antibodies.

SCCPDH is also a potential biomarker for cancer. Because it is expressed in various types of cancer, it can be used as a potential biomarker for cancer.

Currently, scientists are exploring SCCPDH's potential as a drug target or biomarker. There have been some studies showing that SCCPDH can be used as a new method to treat various cancers.

However, at present, in-depth research on SCCPDH still needs to be further understood. More studies are needed to determine SCCPDH's pharmacological effects and value as a cancer biomarker.

SCCPDH is a protein expressed in a variety of cancers and is known for promoting cancer cell growth and proliferation. Therefore, it is a potential drug target or biomarker for breast cancer. In the future, scientists will continue to study SCCPDH in depth to determine its pharmacological effects and evaluate its value in cancer treatment.

Protein Name: Saccharopine Dehydrogenase (putative)

The "SCCPDH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCCPDH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets